Voyager Therapeutics is trading 5.05% down now at $2.54, with no company-specific announcement or catalyst identified in available news and company release results. - The October 2, 2026 decline came as broader markets rose amid softer-than-expected employment data and easing rate concerns. - No clear market-wide explanation for the stock’s drop is established.